Related Experiment Video
Updated: Jun 12, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Short- and Mid-Term Outcomes of Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation in Octogenarians
Yojiro Machii1, Takashi Kakuta1, Naonori Kawamoto1
1Department of Cardiac Surgery, National Cerebral and Cardiovascular Research Center Osaka Japan.
Background:
Robotic mitral valve repair (r-MVr) offers potential advantages, but its safety and feasibility in patients aged ≥80 years remain unclear.
Methods And Results:
This single-center retrospective cohort study included 53 consecutive patients aged ≥80 years who underwent MVr for degenerative mitral regurgitation between April 2011 and July 2025: 31 patients underwent r-MVr using the da Vinci Xi system, and 22 underwent conventional MVr (c-MVr). The primary outcomes were 30-day mortality, major complications, lengths of intensive care unit and hospital stay, and postoperative echocardiography findings. One 30-day death occurred after r-MVr (3.2%) due to intestinal ischemia, and none occurred after c-MVr. The postoperative hospital stay was shorter after r-MVr (12 [interquartile range (IQR), 8-13] vs. 13 [IQR, 12-15] days; P=0.04). The transmitral pressure gradient was lower in the r-MVr group than in the c-MVr group (2.1 [IQR, 2.0-3.0] vs. 3.0 [IQR, 2.0-3.9] mmHg; P=0.02). At the mid-term follow-up, there were no significant differences between the groups in 5-year overall survival (83.3% vs. 95.2%; P=0.32) or freedom from recurrent mitral regurgitation ≥ grade 3 (95.2% vs. 100%; P=0.49).
Conclusions:
r-MVr can be a safe and feasible minimally invasive option with acceptable short- and mid-term outcomes in octogenarians.
Insights
Robotic mitral valve repair (r-MVr) is safe and feasible for octogenarians. This minimally invasive approach shows acceptable short- and mid-term outcomes in patients aged 80 and older.
Area of Science:
- Cardiovascular Surgery
- Minimally Invasive Procedures
- Geriatric Cardiology
Background:
- Robotic mitral valve repair (r-MVr) offers potential benefits but its safety in octogenarians (≥80 years) is not well-established.
- Degenerative mitral regurgitation is a common condition requiring intervention in the elderly population.
Purpose of the Study:
- To evaluate the safety and feasibility of r-MVr in patients aged 80 years and older.
- To compare short- and mid-term outcomes of r-MVr versus conventional MVr (c-MVr) in this specific patient group.
Main Methods:
- Single-center retrospective cohort study of 53 patients (≥80 years) with degenerative mitral regurgitation.
- Comparison between 31 patients undergoing r-MVr (da Vinci Xi system) and 22 patients undergoing c-MVr.
- Primary outcomes included 30-day mortality, major complications, and length of stay; secondary outcomes included echocardiographic findings and mid-term survival.
Main Results:
- One 30-day death occurred in the r-MVr group (3.2%) due to intestinal ischemia; no deaths occurred in the c-MVr group.
- r-MVr was associated with a shorter postoperative hospital stay (12 vs. 13 days; P=0.04).
- Lower transmitral pressure gradient post-procedure in r-MVr group (2.1 vs. 3.0 mmHg; P=0.02) and no significant differences in 5-year survival or freedom from recurrent mitral regurgitation.
Conclusions:
- Robotic mitral valve repair (r-MVr) is a safe and feasible minimally invasive option for octogenarians.
- The procedure demonstrates acceptable short- and mid-term outcomes in patients aged 80 and older.
- r-MVr may be a viable alternative to conventional repair in this elderly demographic.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation IV: Nursing Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction

